Effects of EPA/DHA on skeltal muscle in geriatric type 2 diabetic patients on admission.

Effects of EPA/DHA on skeltal muscle in geriatric type 2 diabetic patients on admission. - Effects of EPA/DHA on skeltal muscle in geriatric type 2 diabetic patients on admission.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038538

Enrollment

Registered

2019-11-11

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Take Omega-3-acid ethyl esters everyday on admission none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients 65 years of age or older Patient's HbA1c is 8.0% and over Patients who have dyslipidemia Patients who provided informed consent and assent

Exclusion criteria

Exclusion criteria: Patients who have a history of hyperglicemic emergency, severe infecitous diseases, major surgery and severe trauma in the past 6 months Patients who will undergo a surgery within 3 months Patients who already take EPA/DHA Patients who have EPA/DHA allergy Patients suffering bleeding disease Patient's eGFR is 30 and less Patients who contact persons judge as ineligible for this study

Design outcomes

Primary

Measure	Time frame
grasping power and creatinine/cystatin C ratio	—

Countries

Japan

Contacts

Public ContactHiroyuki Koyama

Nagoya City University Graduate School of Medical Science Department of Gastroenterology and Metabolism

hk0515@kuhp.kyoto-u.ac.jp052-853-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026